SYNTH-89 · Guide

Static-dynamic (slow, no-relaxation) for endurance?

Untested in trained endurance athletes; no significant 3000 m gain vs controls in 4 weeks (REF-1181); mitochondria unmeasured. Grows muscle in the untrained; no heavy-lifting substitute.

B-limited, mixed evidenceMostly from non-athletes and recreational people

The decision this framework makes

Whether slow, continuous-tension sets at a light load — the Russian static-dynamic method, or its research form LST — belong in an endurance athlete's training, for which goal, at what dose; and what not to promise, so that the method is used where it has evidence (muscle in people who cannot or will not lift heavy) and does not displace the heavy lifting that carries the endurance-performance evidence or the endurance training that builds mitochondria and capillaries.

Key Findings — what the static-dynamic method has and has not been shown to do

1

It builds muscle and strength in untrained people, about as much as or somewhat less than heavy lifting. In 24 untrained young men, 12 weeks of knee extension at about 50% 1RM, 3 s up and 3 s down with no relaxing phase, 3 sets to failure at an 8RM load, grew quadriceps CSA 5.4% against 4.3% at about 80% 1RM (not significantly different, 8 per arm), while the same load and work at normal speed, not to failure, did not; 1RM rose in all three groups with no significant group difference, isometric strength rose more with heavy loads (REF-1171, B+).

A whole-body version (5 exercises, about 55-60% 1RM, twice a week for 13 weeks) raised summed muscle thickness 6.8% and summed 1RM 33.0% against 9.1% and 41.2% with heavy loads — about three-quarters of the heavy gains, no between-group test in the abstract (REF-1172, B+).

The Moscow IBMP trial of training without relaxation at 50% MVC gave +21% strength and +9% muscle volume against +35% and +17% at 80% MVC, not significantly different with 9 per group, on half the work (REF-1169, B); the lab's summary states the heavy gains were larger (REF-1170, C+, abstract).

In adults aged 59-76 the slow style at 50% 1RM raised thigh muscle thickness and knee strength; normal speed at that load raised strength with limited growth (REF-1174, B+, abstract, no heavy group).

2

Effort, not slowness, is the likely driver (the base's inference). With sets taken to failure, repetitions of 0.5-8 s grew muscle alike, and very slow ones (over 10 s) looked inferior on few studies (REF-1176, A-, abstract); with all else equal, about 3.5-s repetitions grew muscle no better than about 1-s ones (difference 0.09 favouring faster, 95% CrI −0.04 to 0.22; REF-1177, A-, abstract).

Light (≤60% 1RM) and heavy loads gave similar hypertrophy when sets went to failure, while 1RM rose more with heavy loads (REF-677, A).

The light arms that did not grow were ones that, as far as the entries say, stopped short of failure: normal-speed 50% 1RM sets of a fixed 8 or 10 repetitions in REF-1171 and REF-1175 (probably far from failure — the entries' inference) and volume-matched 30% 1RM sets short of failure in REF-1178 (B+, abstract; failure and total volume confounded).

In the LST trials the slow arm differed from its light control in tempo, continuous tension and proximity to failure at once, so tempo was never isolated; failure itself is not required, stopping a little short gave nearly the same growth (REF-678, A-).

3

Type I fibre growth: a low-level signal, and not specific to the method. The IBMP summary reports that growth in the area occupied by type I fibres predominated after no-relaxation training at 50% 1RM and type II after 80-85% 1RM — no numbers, n or statistics in the abstract, cohorts likely overlapping, size and fibre share not separated (REF-1170, C+).

In 21 young men, 30% 1RM and 80% 1RM both taken to failure each increased type I fibre CSA (REF-1178, B+, abstract, about 7 per arm, tempo not reported).

Across 8 small randomised biopsy trials (195 young adults, six of eight trials untrained or physically active, loads 15.5-92.5% 1RM, seven of eight to failure; tempo stated only for Schuenke 2012, at 1-2 s per phase, whose slow-speed arm was not among the arms analysed — so no slow no-relaxation sets as far as the review reports, the base's reading), type I fibre growth showed no clear change with load (slope −0.005 SMC per 10% 1RM, 95% CI −0.082 to 0.072) while type II growth leaned upward with heavier loads (0.054, −0.038 to 0.145); the type II minus type I contrast ran from −0.147 at 20% 1RM to 0.265 at 90%, every 95% CI including zero (REF-1195, A-, exploratory).

On the point estimates most of that tilt toward type I at light loads came from type II fibres growing less rather than type I fibres growing more, but the type I slope's CI is wide and in the review's aggregated type II model the two slopes were about equal and opposite (−0.017 vs 0.019), so which fibre type drives it is unsettled (inference).

After 6 weeks of 30% 1RM squats to failure, type I CSA did not rise significantly (P = 0.116; REF-1179, B). In young elite cyclists, 16 weeks of added strength training (programme not described in the abstract) shifted fibres from IIX to IIA with no change in fibre area or capillarisation (REF-075, B).

4

Mitochondria and capillaries: never measured after the method itself; the indirect data are mixed. Light sets to failure at normal tempo (30% 1RM, 1.75 s down and 1.75 s up, about 50-105 s per set by the entry's calculation) raised type I capillary contacts about 18% (4.53 → 5.33) and maximal mitochondrial respiration about 30% in 10 men, with no change in any measured mitochondrial protein; the authors judged resistance exercise insufficient to raise mitochondrial content in 6 weeks, and a thigh cuff on the other leg added no oxidative gain (REF-1179, B, no non-training control). 30% 1RM to failure raised mitochondrial proteins of autophagy, fission and fusion — markers of turnover and remodelling, with no content marker reported (REF-1178, B+, abstract).

One bout of 6-s up / 6-s down repetitions at 30% 1RM to failure raised mitochondrial protein synthesis 114% over 0-6 h, but by 24-30 h a fast bout short of failure had raised it too (REF-1180, C+, n = 8, acute).

LST does deoxygenate the muscle more deeply than heavy or light normal-speed lifting and produces lactate similar to heavy lifting — an acute state, not an adaptation (REF-1171, B+).

Endurance training itself raised mitochondrial content 23-27% across modes (REF-465, A), and capillaries per fibre rise about 10-20% within weeks in untrained people, more slowly in well-trained endurance athletes (REF-466, B+).

5

Endurance performance: no trial in trained endurance athletes. In 34 soldier-runners (12-22 km a week), 4 weeks of slow bodyweight strength work (7-s repetitions, 84-s sets, 4 sets, 90 s rest, twice a week, no progression) raised knee-extension torque 13.3% (slow dynamic sets) and 14.2% (holds) against 2.5% — significant against controls for the holds only — and jump height 5.4% and 4.1% against 0.7%, while the 3000 m improved −2.8% and −2.6% against −0.8% in controls, not significantly (interaction P = 0.421); the trial was underpowered for the time trial and did not measure running economy (REF-1181, B+).

Thirteen weeks of slow no-relaxation squats at about 60% 1RM made pedalling force and quadriceps EMG less variable in non-cyclists (CV −18% and −21%), heavy squats did not; no power, efficiency or performance was measured, so the direction of the effect for cycling is unknown (REF-1173, B).

In runners, submaximal-load strength work (40-79% 1RM) did not significantly improve economy while heavy work did, and across endurance sports heavy maximal-force training beat lighter intensities (SYNTH-44, citing REF-801 and REF-074, A-; the tempo of those lighter programmes is not stated there).

6

Fast strength and power: no significant gain in the loaded trials. Slow squats at 50% 1RM for 8 weeks raised squat 1RM 10% and quadriceps thickness 6-10% but did not significantly change lifting power, leg extension power, the rate of EMG rise or jump height (n = 9; REF-1175, B, abstract).

LST raised no isokinetic knee torque at 90-300 deg/s, and its authors advise adding fast exercise (REF-1171, B+). In isometric training, early rapid force rose only with "fast and hard" contractions (REF-1161, B+, untrained men) — intent the slow method does not train.

The one exception is a low-baseline one: in soldier-runners with little strength-training background, 4 weeks of slow bodyweight sets raised countermovement jump 5.4% against 0.7% in controls (P = 0.003; REF-1181, B+) — an early gain in novices, not evidence that slow sets build power in trained athletes (the base's inference).

7

Lower mechanical stress, not lower metabolic stress. Peak systolic pressure during LST was lower than during heavy lifting (heavy 227.6 ± 24.9 mmHg) at about 60% of the heavy load (REF-1171, B+, acute, untrained young men); creatine kinase rose less and blood lactate more after no-relaxation than after heavy training (REF-1169, B).

The growth-hormone, IGF-1 and cortisol rises after no-relaxation sessions (REF-1169, REF-1170) do not explain the gains: the heavy groups grew at least as much with smaller or no rises, and the metabolite case for hypertrophy is indirect (REF-682, C). The occlusion literature itself lists fast-twitch fibre recruitment among its proposed mechanisms (REF-106, C+).

Default (what to prescribe first)

1

For an endurance athlete with gym access, heavy lifting stays the strength default (SYNTH-43 B+, SYNTH-44 B+); static-dynamic work is not a substitute for it, because lighter-load strength work did less for economy and performance in endurance athletes (SYNTH-44, citing REF-801 and REF-074) and no static-dynamic trial in trained endurance athletes exists.

2

When heavy loading is ruled out or unwanted (a joint, a technique or equipment limit, an introductory block, an athlete who will not lift heavy), slow no-relaxation sets are a reasonable way to keep or build muscle — provided each set ends close to failure, which is what the light arms that grew appear to have had in common (REF-1171, REF-1172, REF-677; "close to failure" rather than "slow" as the active ingredient is the base's inference).

3

Keep something fast in the week — the heavy lifts with fast intent, jumps, or high-cadence riding — because in the loaded trials the slow method did not significantly raise fast strength or power (REF-1175, REF-1171; the jump gain in REF-1181 was in runners new to strength work); the choice of fast element is practice.

4

Build the engine with endurance training, not in the gym: no entry shows the method adding mitochondria or capillaries (REF-465, REF-466; the indirect light-load data are in Key Finding 4).

Decision (goal → what to do)

Goal or situationWhat to doSource and how sure
Strength, economy, sprint and late-race power for a healthy endurance athlete with a gymThe heavy default of SYNTH-43 (cyclists) or SYNTH-44 (runners); static-dynamic work is not a replacement, and adding it on top has no tested benefit (practice)SYNTH-43 B+, SYNTH-44 B+; lighter loads less effective for economy and performance (SYNTH-44 citing REF-801, REF-074, A-); no static-dynamic trial in trained endurance athletes
Muscle size when heavy loads are unwanted (joint, technique, equipment, rehabilitation, preference)Slow no-relaxation sets at about 50-60% 1RM, each set ending near failure; expect size gains from about equal to clearly smaller than heavy (about half in the Moscow trial) and somewhat smaller 1RM gainsREF-1171 B+ (+5.4% vs +4.3% CSA, 1RM no group difference, n = 24 untrained); REF-1172 B+ (+6.8% vs +9.1% thickness, +33.0% vs +41.2% 1RM, abstract); REF-1169 B (+9% vs +17% volume, 9 per group); REF-677 A; all untrained or recreational — TRANSFER
"Grow my slow-twitch fibres"Not a reason to choose the method: the type I signal is low-level, heavy loads to failure grew type I fibres too, and across 8 biopsy trials type I growth showed no clear dependence on load; the one elite-cyclist strength trial with fibre data saw a IIX → IIA shift, not type I growthREF-1170 C+ (type I area predominated, abstract, no numbers); REF-1178 B+ (30% and 80% to failure both grew type I CSA, abstract); REF-1179 B (type I CSA not significant); REF-1195 A- (type I slope −0.005 SMC per 10% 1RM, 95% CI −0.082 to 0.072; all fibre-type contrasts include zero; 8 small trials, mostly untrained, tempo mostly unreported); REF-075 B (elite cyclists, IIX → IIA, no fibre-area change)
"Build mitochondria and capillaries"Endurance training, not the gym. If an athlete still wants light sets, call any oxidative effect possible and unprovenREF-465 A (+23-27% mitochondrial content across modes); REF-466 B+ (capillaries +10-20% in untrained, slower in trained); indirect only: REF-1179 B (respiration ~+30%, type I capillary contacts ~+18%, no mitochondrial protein change, normal tempo), REF-1178 B+ (turnover proteins), REF-1180 C+ (acute synthesis, n = 8)
Faster 3000 m, time trial or raceNo evidence that the method helps; do not add it for an aerobic benefitREF-1181 B+ (−2.8% vs −0.8% in controls, P = 0.421, 4 weeks, underpowered, economy not measured); REF-1173 B (pedalling pattern only)
Power, sprint, jump, climbing punchHeavy lifting with fast intent, jumps or explosive work — not slow setsREF-1175 B (no significant change in power or jump, n = 9, abstract); REF-1171 B+ (no fast isokinetic gain); REF-1181 B+ (slow bodyweight sets did raise jump 5.4% vs 0.7% in runners new to strength work, 4 weeks); REF-1161 B+ (rapid force only with explosive intent, isometric); SYNTH-43, SYNTH-44
Cyclist asking about pedallingDo not use the method as a pedalling tool; if it is used, keep riding-specific and high-cadence work in the week (practice)REF-1173 B (force CV −18%, EMG CV −21% in non-cyclists; authors flag a possible downside; performance not measured)
Masters athlete who avoids heavy loadsA reasonable way to add thigh muscle at about half of 1RM; heavy loading is not off-limits with age, and power needs fast work, so add fast-intent sets (practice)REF-1174 B+ (59-76 y, thickness and strength up, abstract, no heavy group); SYNTH-43 (heavy ≥70% 1RM built more leg strength than lighter loads in adults 50+, and high-velocity training beat slow lifting for leg power)
Lower blood pressure during the lift, introductory or rehabilitation blockAn option: peak systolic pressure was lower than with heavy lifting, at a lower external load; clear any blood-pressure condition with the physician (practice)REF-1171 B+ (acute, untrained young men; heavy 227.6 ± 24.9 mmHg, LST lower); resting blood pressure is a different goal — isometric holds, SYNTH-88
Low-fatigue maintenance in season or a race blockNot shown to be lower-fatigue: no entry measured its fatigue cost, and blood lactate (a metabolic marker, not a fatigue measure) was similar to heavy lifting. The tested in-season dose stays one heavy session a week (SYNTH-43); short maximal or explosive holds are the other low-fatigue option (SYNTH-88, practice)REF-1171 B+ (lactate similar to heavy); REF-1169 B (CK lower, lactate higher than heavy); no entry measured the method's fatigue cost
Travel, no gym, bodyweight onlySlow bodyweight sets (7-s repetitions, 84-s sets) raised knee torque and jump height in runners with little strength-training background; use them as a bridge back to loaded work, not as a block of their own (practice)REF-1181 B+ (slow dynamic group: torque +13.3% vs +2.5%, P = 0.063 against controls; jump +5.4% vs +0.7%, P = 0.003; 4 weeks; no progression); SYNTH-44 (circuits and bodyweight are a fallback)
Cuff blood flow restriction insteadA different method with its own evidence, protocol and safety rules; the no-cuff static-dynamic method has not been tested against it, and in one study a cuff added no oxidative gain to light sets to failureREF-566 A (position stand: hypertrophy comparable to heavy, strength smaller); REF-105 A- (BFR added to training in endurance athletes); REF-707 B (no added benefit in well-trained cyclists); REF-1179 B

Practical Application

Static-dynamic (slow, no-relaxation) for endurance? Untested in trained endurance athletes; no significant 3000 m gain vs controls in 4 weeks (REF-1181); mitochondria unmeasured. Grows muscle in the untrained; no heavy-lifting substitute.
If an athlete wants to use it (practice, built on the LST trials): 2-4 lower-body exercises (leg press or squat, split squat, calf raise — the choice is practice); a load of about 50-60% 1RM that, at 3 s down and 3 s up without resting at the top or bottom, ends the set within about 1-2 repetitions of failure at roughly 40-60 s (the trials used an 8RM load in that style, about 48-56 s, REF-1171, REF-1172); 3 sets with 60 s rest as tested in REF-1171 (Seluyanov-style 30 s rests and partial range are practice — no entry tested them; training at longer vs shorter muscle lengths barely changed regional growth in REF-1168, A-); twice a week (as in REF-1172, REF-1173); judge it after 8-12 weeks (the trials ran 8-13).Place it in the week as you would a heavy leg session and keep a fast element (practice).
Athlete told it builds slow-fibre mitochondria: no entry measured mitochondria or capillaries after slow no-relaxation training; the nearest chronic data are normal-tempo light sets to failure, which raised respiration and type I capillary contacts in 10 men without raising mitochondrial proteins (REF-1179, B). Endurance training remains the lever (REF-465, A).
Masters athlete with sore joints: slow sets at about half of 1RM grew thigh muscle in adults aged 59-76 (REF-1174, B+); offer them as the joint-friendly route (the joint benefit is the base's reading of the lower load, not a measured outcome), add fast-intent work for power, and keep heavy loading in view where it is tolerated (SYNTH-43).
Cyclist using it in winter: treat it as muscle work only; keep high-cadence and riding-specific sessions in the same weeks, because slow squats changed the pedalling pattern of non-cyclists in a direction of unknown value (REF-1173, B; the high-cadence advice is practice).
Judge a light set by how it ends, not by its tempo or burn: light sets that grew muscle ended near failure, light sets that stopped short did not (REF-1171, REF-1175, REF-1178; 'far short' in the first two is the entries' inference); the burn is a by-product, not the target (the base's inference).

What NOT to claim

Do not say the method builds mitochondria or capillaries in slow fibres. No entry measured either after slow no-relaxation training. Light sets to failure raised respiration and capillary contacts but not mitochondrial proteins at normal tempo (REF-1179, B), and raised turnover and remodelling proteins with no content marker reported at an unreported tempo (REF-1178, B+), and one slow bout raised acute synthesis that a fast bout matched the next day (REF-1180, C+).
Do not say it improves endurance performance. The only endurance trial (4 weeks, bodyweight, recreational soldier-runners) found no significant 3000 m difference and did not measure economy (REF-1181, B+); no trial exists in trained endurance athletes; lighter-load strength work did not significantly improve runners' economy (SYNTH-44, citing REF-801).
Do not say it is proven to grow type I fibres specifically. That rests on an abstract with no numbers (REF-1170, C+), heavy loads to failure grew type I fibres too (REF-1178, B+), and across 8 biopsy trials type I growth was flat from light to heavy loads (REF-1195, A-, imprecise).
Do not say the slow tempo is what grows muscle. Tempo barely mattered in two meta-analyses (REF-1176, REF-1177, A-); light loads matched heavy ones for size when sets went to failure (REF-677, A), and the light arms stopped short of failure did not grow significantly (REF-1171, REF-1175, REF-1178).
Do not say it equals heavy lifting for strength. 1RM gains favour heavy loads (REF-677, A); heavy groups had larger isometric strength (REF-1171) and larger point estimates (REF-1172, REF-1169).
Do not sell it for power, speed or a better pedal stroke (REF-1175, B; REF-1171, B+; REF-1173, B).
Do not explain it by the hormone surge (REF-682, C; the heavy groups grew at least as much without it, REF-1169).
Do not equate it with cuff blood flow restriction. The cuff studies are a different method (REF-566, REF-105, REF-707); the no-cuff method's self-occlusion lowers muscle oxygenation acutely (REF-1171), but whether it reproduces a cuff's training effects is untested, and the cuff added no oxidative gain in REF-1179.
Do not call it the low-fatigue option. Its fatigue cost was never measured; blood lactate was similar to heavy lifting (REF-1171, B+) and creatine kinase rose less (REF-1169, B), markers that point in opposite directions.

Limitations

No entry tests the static-dynamic prescription as coaches use it (partial range, 30-60 s sets to a burn, about 30 s rests; a practice description); the closest tested forms are the IBMP no-relaxation trials, whose abstracts give no tempo or set structure (REF-1169, REF-1170), and the Japanese LST trials (REF-1171 to REF-1175; full range, 60 s rests and sets to failure at an 8RM load are stated only in REF-1171, 8RM sets also in REF-1172; the other abstracts give no rest or range, and REF-1175 used a fixed 10 repetitions).
Almost no evidence in endurance athletes: the training trials are untrained young men, physically active young men and older adults; the one endurance trial is 4 weeks of bodyweight work in recreational soldier-runners (REF-1181); no cycling trial with a performance outcome exists.
Trials are small (7-12 per arm in most) and short (4-13 weeks); the IBMP cohorts likely overlap and their randomisation is not stated (REF-1169, REF-1170); several entries are read from the abstract only (REF-1169, REF-1170, REF-1172 to REF-1178).
The oxidative evidence is indirect: no biopsy study used slow no-relaxation sets for training; the chronic biopsy studies used normal-tempo or unreported-tempo light sets to failure (REF-1178, REF-1179), and the slow-tempo study was one acute session (REF-1180).
"Effort, not tempo" is the base's inference: tempo meta-analyses held effort constant at failure (REF-1176) or controlled other variables (REF-1177), and in every LST trial with a light control (REF-1171, REF-1174, REF-1175) the slow arm also differed from it in effort (by design in REF-1171, by the entries' inference in the others).
The prescription, the joint-friendly reading, the masters and travel uses, the fast-element advice and every dose for endurance athletes are the base's practice.
Created 2026-10-16 from the static-dynamic batch REF-1169 to REF-1181 (after that batch's verifier fixes of the same day) with REF-677, REF-678, REF-682, REF-513, REF-106, REF-105, REF-102, REF-566, REF-707, REF-465, REF-466, REF-075, REF-529, REF-1158, REF-1161, REF-1168, SYNTH-43, SYNTH-44 and SYNTH-88; 12 goal rows; level B-.
Revision 2026-10-26: folded REF-1195 (Varovic 2026, A-, exploratory meta-regression of 8 small randomised biopsy trials, 195 young adults, mostly untrained, full text): type I fibre growth showed no clear dependence on load (slope −0.005 SMC per 10% 1RM, 95% CI −0.082 to 0.072), the type II tilt toward heavy loads was imprecise (all contrasts' 95% CIs include zero); added to the summary, the Level line, Key Finding 3, the slow-twitch row, the type I What-NOT-to-claim line and Cross-References.It strengthens "not a reason to choose the method" without changing a rule; it tested load, not tempo or no-relaxation sets; level unchanged (B-).
How this entry was checked and changed
Why this level

(muscle size and strength on an A meta-analysis of light vs heavy loads to failure REF-677, two A- tempo meta-analyses read from their abstracts REF-1176 REF-1177, B+ LST trials of 24-36 untrained young men or older adults REF-1171 REF-1172 REF-1174 and B trials of 16-18 men REF-1169 REF-1175; type I fibres on a C+ laboratory summary read from its abstract REF-1170, with a B+ abstract-only trial in which heavy loads to failure grew type I fibres as well REF-1178 and an A- exploratory meta-regression of 8 small biopsy trials, mostly in untrained people, in which type I growth showed no clear dependence on load and every fibre-type contrast was imprecise REF-1195; mitochondria and capillaries only indirectly, from light sets to failure at unreported or normal tempo (B+ from the abstract, B) and one acute C+ session REF-1178 REF-1179 REF-1180; endurance performance on one underpowered 4-week B+ trial of slow bodyweight sets in recreational soldier-runners REF-1181 and a B pedalling-pattern surrogate in non-cyclists REF-1173; no trial in trained endurance athletes; the "heavy stays the default" half carries SYNTH-43 and SYNTH-44 (B+); the prescription and every dose for endurance athletes are practice)